Keryx Biopharma Reports Zerenex Phase 2 Results in Non-Dialysis Dependent ... Benzinga Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") today announced that Phase 2 clinical results of Zerenex™ (ferric citrate coordination complex) in non-dialysis dependent chronic kidney disease (NDD-CKD) patients with elevated serum ... GlobeNewswire Press Release: Keryx Biopharmaceuticals, Inc. |
